GlassScriptPhysician profile
Kevin Kaufman
NPI 1497736391
$6,206.56
in general payments reported to CMS, 2019-2025
25 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $333 · 2021: $412 · 2022: $562 · 2023: $1,219 · 2024: $1,667 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,353 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,353.49 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,136.39 | 2022-2025 | |
| Alcon Vision LLC | $732.62 | 2019-2025 | Hydrus Microstent, Argos, Clareon Panoptix Pro |
| Amgen INC. | $484.65 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $468.69 | 2022-2025 | Cequa |
| Aerie Pharmaceuticals, INC. | $443.71 | 2019-2021 | |
| Oyster Point Pharma, INC. | $360.05 | 2022-2024 | Tyrvaya, Ryzumvi |
| Rxsight INC | $324.83 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Allergan, INC. | $314.50 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $314.44 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Dompe US, INC. | $234.85 | 2019-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $212.94 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $211.16 | 2022-2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $142.10 | 2021 | |
| Sight Sciences, INC. | $138.04 | 2019-2025 | Omni Surgical System |
| Novartis Pharmaceuticals Corporation | $104.29 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $99.58 | 2023 | Tecnis Iol |
| Biotissue Holdings INC. | $97.36 | 2020-2024 | |
| Glaukos Corporation | $91.10 | 2021-2024 | Radius |
| Rayner Intraocular Lenses Limited | $66.66 | 2023-2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| New World Medical,INC. | $65.37 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.64 | 2019-2021 | |
| Optos, INC. | $41.01 | 2021 | |
| Apellis Pharmaceuticals, INC. | $38.97 | 2025 | Syfovre |
| Thea Pharma INC. | $24.49 | 2023 | Iyuzeh |
| Lkc Technologies, INC. | $14.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.